Home/Filings/4/0001493152-22-006879
4//SEC Filing

Levine Mitchell S 4

Accession 0001493152-22-006879

CIK 0001642380other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:19 PM ET

Size

5.0 KB

Accession

0001493152-22-006879

Insider Transaction Report

Form 4
Period: 2022-03-15
Levine Mitchell S
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, no par value

    2022-03-15$1.17/sh+25,000$29,15087,080 total
Footnotes (1)
  • [F1]The price of $1.166 per share represents a weighted average of prices ranging from $1.155 to $1.180 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001383492

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:19 PM ET
Size
5.0 KB